iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage

    NEXT STORY
    CymaBay Therapeutics Announces Departure of Chief Medical Officer
    PREV STORY
    SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer shows positive data in those with liver metastases

    author_avatar
    NASDAQ Market News

    New Children’s Chapter Book Promotes Benefits of Practicing Mental and Physical Activities

    author_avatar
    NASDAQ Market News

    EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™

    author_avatar
    NASDAQ Market News